Montel Williams: Israel leads in medical marijuana

October 31, 2011 By ARON HELLER , Associated Press in Medications

Montel Williams: Israel leads in medical marijuana (AP)

Enlarge

Emmy Award-winning television personality Montel Williams speaks during an interview with the Associated Press in Jerusalem, Sunday, Oct. 30, 2011. Williams says Israel is at the forefront of providing patient access to medical marijuana. Williams was diagnosed with multiple sclerosis in 1999. He has since been an outspoken advocate of medical marijuana to relieve pain caused by disease. (AP Photo/Sebastian Scheiner)

(AP) -- Emmy Award-winning television personality and patient activist Montel Williams said Sunday he was impressed with Israel's liberal attitude toward medical marijuana, and he believes the U.S. could learn a thing or two from the Jewish state.

Williams was diagnosed with multiple sclerosis in 1999 and he has since been an outspoken advocate of medical marijuana to relieve caused by the disease.

The former host of the popular long-running talk show "The Montel Williams Show" is in Israel on a fact-finding mission to learn about its medicinal cannabis practices. He is meeting with legislators, scientists and physicians.

At the height of his TV career, Williams was one of the most recognizable faces in America alongside fellow daytime TV hosts , Phil Donahue and Geraldo Rivera.

"We need to get out of the dark ages and into the new ages," he told The Associated Press. "Not every patient can use cannabis, but for those who can - why deny it?"

In Israel, certain doctors can approve cannabis prescriptions and disperse them to patients, said Itay Goor-Aryeh, the head of the pain management unit at the Sheba Medical Center in central Israel.

He said that while marijuana use is strictly regulated, many doctors prefer prescribing it to patients who qualify because it is "the lesser of evils."

"Those patients, if they do not get cannabis, they will get morphine-like drugs and other harmful drugs," said Goor-Aryeh. "I think that in many ways, cannabis is tolerated and is less addictive that morphine-based drugs."

Sixteen U.S. states have decriminalized the use of to some extent. Critics claim dispensaries are often no more than fronts.

Williams said that those merely seeking to smoke pot won't go through the lengthy bureaucratic process when they could just "go down the street."

Williams, 55, said he takes cannabis on a daily basis.

"For me, there is nothing else that can do what it does," he said. "It helps me suppress my pain ... When I am not using I am thinking about my pain every 45 seconds."

He said the drug has been "vilified to substantiate the false reason why it was banned in the first place," and that he hoped it would one day become a regular prescription drug.

"There are chemicals within that plant," he said, "and some of the leading science on where and how those chemicals work is being done right here in this country," referring to Israel.

©2011 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

Experts favor US approval of Merck sleeping pill (Update)

An independent panel of experts on Wednesday recommended US approval of a new Merck sleeping pill called suvorexant, but expressed concerns over the highest dosage and risks of drowsy daytime driving.

Medications created 3 hours ago | popularity not rated yet | comments 0

Glaxo, US partnering to develop new antibiotics

GlaxoSmithKline PLC says it's starting an unusual collaboration with the U.S. government to develop several antibiotics for both bioterrorism threats and bacterial infections resistant to current medicines.

Medications created 5 hours ago | popularity not rated yet | comments 0

Study finds new pneumococcal vaccine appears to be as safe as previously used vaccine

The new 13-valent pneumococcal conjugate vaccine (PCV13) appears to be as safe as the previous version used prior to 2010, the 7-valent pneumococcal conjugate vaccine (PCV7), according to a Kaiser Permanente study published ...

Medications created 11 hours ago | popularity not rated yet | comments 0

Succesful results in developing oral vaccine against diarrhea

The University of Gothenburg Vaccine Research Institute (GUVAX) announces successful results in a placebo controlled phase I study of an oral, inactivated Escherichia coli diarrhea vaccine.

Medications created 13 hours ago | popularity not rated yet | comments 0

New sleeping pill poised to hit US markets

An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.

Medications created May 21, 2013 | popularity 4.2 / 5 (5) | comments 0


Slowing the aging process—only with antibiotics

Swiss scientists reveal the mechanism responsible for aging hidden deep within mitochondria—and dramatically slow it down in worms by administering antibiotics to the young.

Researchers complete largest genetic sequencing study of human disease

Researchers from Queen Mary, University of London have led the largest sequencing study of human disease to date, investigating the genetic basis of six autoimmune diseases.

Brain can be trained in compassion, study shows

Until now, little was scientifically known about the human potential to cultivate compassion—the emotional state of caring for people who are suffering in a way that motivates altruistic behavior.

Having both migraines, depression may mean smaller brain

(HealthDay)—Migraines and depression can each cause a great deal of suffering, but new research indicates the combination of the two may be linked to something else entirely—a smaller brain.

Novel approach for influenza vaccination shows promise in early animal testing

A new approach for immunizing against influenza elicited a more potent immune response and broader protection than the currently licensed seasonal influenza vaccines when tested in mice and ferrets. The vaccine ...

Enzyme-activating antibodies revealed as marker for most severe form of rheumatoid arthritis

In a series of lab experiments designed to unravel the workings of a key enzyme widely considered a possible trigger of rheumatoid arthritis, researchers at Johns Hopkins have found that in the most severe ...